IL18 and acute kidney injury: Several biomarkers such as NGAL, KIM-1, L-FABP, or IL-18 are able to exclude the ATN-AKI with great accuracy; however, for some of them the exact specificity and sensitivity remain unclear and emphasize the need for further studies on different populations.